Epsilon Molecular Engineering operates as an evolutionary molecular engineering-based biopharmaceutical drug discovery company. It is a bio-venture company conducting research and development of new-generation biopharmaceuticals using VHH antibodies, cyclic peptide aptamers, and new scaffold biomolecules. The company was founded in 2016 and is based in Saitama, Japan.

Sequentify provides a technology that is based on tools from the synthetic biology and AI software worlds for targeted DNA sequencing applications, such as cancer diagnostics, carrier screening, COVID-19 surveillance, and other applications. It was founded in 2021 and is based in Rehovot, Israel.

Molecular Loop Biosciences is a biotechnology firm offering solutions for production-scale targeted sequencing applications.

DNA Script is a biotech start-up that manufactures de novo synthetic nucleic acids using an enzymatic technology. The company aims to introduce a biochemical process for DNA and RNA synthesis based on the use of efficient enzymes. This technology mimics the way nature produces genetic code and enables enhanced performance while minimizing the use of harsh chemicals.

Evonetix develops a desktop, short-latency solution to synthesize DNA to facilitate the field of synthetic biology, with applications across industries including healthcare, pharma, biotech, food and agriculture, and data storage. It leverages semiconductor-controlled synthesis on silicon which enables ultra-parallel DNA preparation, and moving capacity from remote service centers. The company was founded in 2015 and is based in Cambridge, U.K.

Molecular Assemblies develops an enzymatic DNA synthesis technology designed to power DNA-based products. Enzymatic DNA synthesis can write long, pure DNA, which is required to free the potential of synthetic biology applications, such as personalized medicines (including CAR-T cell therapies and CRISPR gene editing) and advanced agricultural and industrial products, through gene development and DNA-based data storage.